tm logo
OPSUMIT
Live/Registered
REGISTERED AND RENEWED

on 21 Mar 2022

Last Applicant/ Owned by

Gewerbestrasse 16

Allschwil

CH

CH-4123

Serial Number

85329499 filed on 25th May 2011

Registration Number

4056510 registered on 15th Nov 2011

in the Principal Register

Correspondent Address

Cheryl Foytlin

Johnson & Johnson

ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK, NJ 08933

Filing Basis

1. intent to use

Disclaimer

NO DATA

OPSUMIT

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases [ ; Pharmaceutical preparations for the treatment of inflammatory diseases; ] [ Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of auto-immune disorders; Pharmaceutical preparations for the treatment of digital ulcers ]

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases [ ; Pharmaceutical preparations for the treatment of inflammatory diseases; ] [ Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of auto-immune disorders; Pharmaceutical preparations for the treatment of digital ulcers ]

Mark Details


Serial Number

No 85329499

Mark Type

No Service/Collective Mark

Attorney Docket Number

No T41866US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Mar 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
21st Mar 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
21st Mar 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21st Mar 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Nov 2021TEAS SECTION 8 & 9 RECEIVED
15th Nov 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Mar 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06th Mar 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th Feb 2017NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07th Feb 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED